Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3
Drug Metabolism and Disposition · 2025-09 · 53 (9) · 100142
DOI: 10.1016/j.dmd.2025.100142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025-09. Verfasst von Cátia F Marques und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Flunitrazepam, 3-Hydroxysteroid Dehydrogenases, Hydroxyprostaglandin Dehydrogenases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, NIH HHS, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Center of Excellence in Environmental Toxicology, Perelman School of…
Förderung
- NIEHS NIH HHS
- NIH HHS
- National Institute of Environmental Health Sciences
- National Institutes of Health
- National Institutes of Health Office of Research Infrastructure Programs
- American Cancer Society
Zitieren
APA
Marques, C. F., Narang, M., Sharp, K. A., & Penning, T. M. (2025). Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3. Drug Metabolism and Disposition, 53(9), 100142. https://doi.org/10.1016/j.dmd.2025.100142
Vancouver
Marques CF, Narang M, Sharp KA, Penning TM. Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3. Drug Metabolism and Disposition. 2025;53(9):100142. doi:10.1016/j.dmd.2025.100142
BibTeX
@article{Marques2025,
author = {Marques, Cátia F and Narang, Maya and Sharp, Kim A and Penning, Trevor M},
title = {Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3},
journal = {Drug Metabolism and Disposition},
year = {2025},
volume = {53},
number = {9},
pages = {100142},
doi = {10.1016/j.dmd.2025.100142}
}
EUVIMED